Future of the Pharmaceuticals Native Starch Market: Trends, Innovations, and Key Forecasts Through 2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Pharmaceuticals Native Starch Market Size Growth Forecast: What to Expect by 2025?
The market size of native starch in the pharmaceutical industry has witnessed considerable growth in recent years. The market size is anticipated to surge from $5.65 billion in 2024 to $6.11 billion in 2025, marking a compound annual growth rate (CAGR) of 8.1%. This historic growth phase is primarily credited to a surge in demand for natural excipients, an increase in pharmaceutical production, heightened inclination towards biocompatible constituents, expansion in the manufacture of generic drugs, and escalating regulatory endorsement for natural ingredients.

How Will the Pharmaceuticals Native Starch Market Size Evolve and Grow by 2029?
In the coming years, a robust expansion is projected for the native starch market in the pharmaceutical industry with the market size likely reaching "$8.5 billion by 2029", growing at a compound annual growth rate (CAGR) of 8.6%. This forecasted growth can be linked to factors such as an increase in investments towards pharmaceutical ingenuity, a growing emphasis on sustainable sourcing, widening application of novel drug formulations, a surge in demand for clean-label pharmaceutical goods, and increased healthcare spending in emerging markets. Key trends anticipated during the forecast period comprise advancements in starch processing technology, innovation in drug delivery systems, progress in bio-based pharmaceutical components, R&D in plant-based excipients, and the evolution of solutions for solubility and stability.

View the full report here:
https://www.thebusinessresearchcompany.com/report/pharmaceuticals-native-starch-global-market-report

What Drivers Are Propelling the Growth of Pharmaceuticals Native Starch Market Forward?
The growing occurrence of chronic illnesses is anticipated to drive the expansion of the pharmaceuticals native starch market. Chronic illnesses are medical conditions that usually develop slowly and last for at least a year. The rising incidence of these conditions is largely due to the growing elderly population, who are more prone to persistent health issues such as diabetes, cardiovascular ailments, arthritis, and cancer. These health issues tend to become increasingly prevalent as one gets older. Native starch used in pharmaceuticals aids in managing these chronic illnesses by boosting the stability of drug composition, improving bioavailability, facilitating controlled drug release, fostering patient adherence, and enhancing the efficacy and long-term management of chronic health problems. For example, data from the Australian Institute of Health and Welfare, a government agency in Australia, in June 2024 indicated that the mortality rate from chronic conditions had risen from 459 per 100,000 people in 2021 to 490 per 100,000 people in 2022. Thus, the escalating occurrence of chronic diseases is fuelling the expansion of the pharmaceuticals native starch market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24376&type=smp

What Are the Key Trends Driving Pharmaceuticals Native Starch Market Growth?
Prominent entities in the pharmaceuticals native starch market are placing emphasis on the creation of innovative products like plant-based textures with the aim to refine drug formulation and boost patient compliance. Plant-based texture, defined by attributes gained from plant components such as thickness and gel strength, aids pharmaceuticals in the application of native starch by amplifying tablet binding, disintegration, and oral sensation for enhanced natural drug configurations. For example, in February 2024, Ingredion Incorporated, an American food corporation, introduced Novation Indulge 2940 starch, a clean-label texture enhancer devised to amplify texture and stability in dairy and dairy-alternative items. This pioneering pharmaceutical native starch presents functional traits that improve drug formulation efficiency, bioavailability, and regulated release, fostering the development of clean-label, eco-friendly products. NOVATION Indulge 2940 starch serves as a flexible component that betters texture, endurance, and consumer acceptance in dairy and dairy-alternative products via the use of clean-label, natural ingredients.

What Are the Key Segments in the Pharmaceuticals Native Starch Market?
The pharmaceuticals native starch market covered in this report is segmented -

1) By Type: Potato Starch, Corn Starch, Other Types
2) By Formulation Type: Oral Solid Dosage Forms, Liquid Dosage Forms, Topical Formulations, Injectable Drugs, Controlled Release Formulations
3) By Functionality: Texturizing Agent, Moisture Retention Agent, Bulking Agent, Emulsifying Agent, Film-Forming Agent
4) By Application: Binders And Coating Agents, Disintegrants, Fillers And Extenders, Stabilizers, Thickening Agents
5) By End-User: Pharmaceutical Manufacturers, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), Research And Development Labs, Academic Institutions, Other End-users

Subsegments:
1) By Potato Starch: Modified Potato Starch, Native Potato Starch
2) By Corn Starch: Modified Corn Starch, Native Corn Starch
3) By Other Types: Rice Starch, Wheat Starch, Tapioca Starch

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24376&type=smp

Who Are the Key Players Shaping the Pharmaceuticals Native Starch Market's Competitive Landscape?
Major companies operating in the pharmaceuticals native starch market are Cargill Incorporated, Archer Daniels Midland Company, Ingredion Incorporated, Tereos SCA, Roquette Frères SA., AGRANA, Tate & Lyle Public Limited Company, Colorcon Inc., Grain Processing Corporation, Siam Modified Starch Co. Ltd., BENEO GmbH, Gulshan Polyols Ltd., SPAC Starch Products (India) Private Limited, Universal Starch-Chem Allied Ltd., Sanstar Biopolymers Ltd., Emsland Group, Hungrana Kft., Bluecraft Agro Pvt. Ltd., Visco Starch, Shandong Liujia Pharmaceutical Excipient Co.Ltd.

What Geographic Markets Are Powering Growth in the Pharmaceuticals Native Starch Market?
North America was the largest region in the pharmaceuticals native starch market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceuticals native starch market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24376

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.